Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Cornelia Braicu; Valentina Pileczki; Laura Pop; Roxana Cojocneanu Petric; Sergiu Chira; Eve Pointiere; Patriciu Achimas-Cadariu; Ioana Berindan-Neagoe

doi:10.1371/journal.pone.0120936

Loading metrics

Open Access

Peer-reviewed

Research Article

Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Cornelia Braicu,

Affiliation Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
⨯
Valentina Pileczki,

Affiliations Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
⨯
Laura Pop,

Affiliation Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
⨯
Roxana Cojocneanu Petric,

Affiliations Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania, Faculty of Biology and Geology, Babeş-Bolyai University, Cluj-Napoca, Romania
⨯
Sergiu Chira,

Affiliation Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
⨯
Eve Pointiere,

Affiliation Haute École Louvain en Hainaut, Fleurus, Belgique
⨯
Patriciu Achimas-Cadariu ,

* E-mail: ioananeagoe29@gmail.com (IBN); pachimas@umfcluj.ro (PAC)

Affiliations Department of Surgery, The Oncology Institute " Prof Dr. Ion Chiricuta", Cluj-Napoca, Romania, Department of Surgical Oncology and Gynaecological Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
⨯
Ioana Berindan-Neagoe

* E-mail: ioananeagoe29@gmail.com (IBN); pachimas@umfcluj.ro (PAC)

Affiliations Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Immunology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Functional Genomics and Experimental Pathology, The Oncology Institute " Prof Dr. Ion Chiricuta", Cluj-Napoca, Romania, Department of Experimental Therapeutics M.D. Anderson Cancer Center Houston, Texas, United States of America
⨯

Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model

Cornelia Braicu,
Valentina Pileczki,
Laura Pop,
Roxana Cojocneanu Petric,
Sergiu Chira,
Eve Pointiere,
Patriciu Achimas-Cadariu,
Ioana Berindan-Neagoe

Published: April 7, 2015
https://doi.org/10.1371/journal.pone.0120936

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Autophagic cell death
Is the Subject Area "Autophagic cell death" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.